Application for the renewal of the approval of the active substance penthiopyrad was submitted in accordance with Commission Implementing Regulation (EU) 2020/1740 [Commission Implementing Regulation (EU) 2020/1740 of 20 November 2020 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and repealing Commission Implementing Regulation (EU) No 844/2012 (OJ L 392, 23.11.2020, p. 20, ELI: http://data.europa.eu/eli/reg_impl/2020/1740/oj).]. On 19 January 2023, the rapporteur Member State informed the co-rapporteur Member States, the Commission and the Authority that they had assessed the admissibility pursuant to Article 8 of Implementing Regulation (EU) 2020/1740, and in particular the completeness and the timeliness, of the application and concluded that it was admissible.
Recital 3, Regulation (EU) 2025/2027
In forcesince 9 Oct 2025